News

ClearSight, a leading provider of advanced vision correction solutions, is now offering the PanOptix® Trifocal Intraocular ...
In the evolving field of neurodegenerative medicine, the challenge is not merely discovering new treatments but ensuri ...
An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...
Gordon Schanzlin New Vision Institute (GSNVI), a leading provider of advanced eye care in Southern California, is proud to announce it will soon offer Alcon’s revolutionary Sitemap™ diagnostic ...
Following his keynote address at Controversies in Modern Eye Care, Dr. Maloney said he will be leaving his surgical practice ...
An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...
Leading oncologists said AI will one day be as integrated into cancer care as it is in smartphones and self-driving cars. #STATBreakthrough ...
A widely available and low-cost HIV medication, lamivudine, may offer new hope for millions of people suffering from diabetic macular edema (DME), a leading cause of vision loss among diabetics.